Disclosing Adverse Events to Patients

Author： Cantor Michael D.   Barach Paul   Derse Arthur   Maklan Claire W.   Wlody Ginger Schafer   Fox Ellen  

Publisher： Joint Commission Resources

ISSN： 1553-7250

Source： Joint Commission Journal on Quality and Patient Safety, Vol.31, Iss.1, 2005-01, pp. : 5-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Physician shame: an obstacle to disclosing adverse outcomes

By Bancroft Nancy Parent  

Clinician in Management, Vol. 15, Iss. 1, 2007-03 ,pp. : 3-10

Radcliffe Press

Access to resources Recommend Favorite

Adverse drug events in patients admitted to an emergency department: an analysis of direct costs

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 2, 2015-02 ,pp. : 176-186

John Wiley & Sons Inc

Access to resources Recommend Favorite

The risk of perioperative adverse events in patients with chronic liver disease

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 713-723

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adverse events in hospitalized paediatric patients: a systematic review and a meta‐regression analysis

By  

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol. 20, Iss. 5, 2014-10 ,pp. : 551-558

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular and pulmonary adverse events in patients treated with BCR‐ABL inhibitors: Data from the FDA Adverse Event Reporting System

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 4, 2015-04 ,pp. : E66-E72

John Wiley & Sons Inc

Access to resources Recommend Favorite